rs139332405
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS1
The NM_004370.6(COL12A1):c.2965G>A(p.Gly989Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,613,676 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G989A) has been classified as Likely benign.
Frequency
Consequence
NM_004370.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL12A1 | NM_004370.6 | c.2965G>A | p.Gly989Arg | missense_variant | 14/66 | ENST00000322507.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL12A1 | ENST00000322507.13 | c.2965G>A | p.Gly989Arg | missense_variant | 14/66 | 1 | NM_004370.6 | P4 | |
COL12A1 | ENST00000345356.10 | c.74-13043G>A | intron_variant | 1 | |||||
COL12A1 | ENST00000483888.6 | c.2965G>A | p.Gly989Arg | missense_variant | 14/65 | 5 | A1 | ||
COL12A1 | ENST00000416123.6 | c.2965G>A | p.Gly989Arg | missense_variant | 13/63 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00249 AC: 379AN: 152128Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00226 AC: 563AN: 248684Hom.: 0 AF XY: 0.00217 AC XY: 293AN XY: 135002
GnomAD4 exome AF: 0.00184 AC: 2692AN: 1461430Hom.: 1 Cov.: 31 AF XY: 0.00180 AC XY: 1308AN XY: 727012
GnomAD4 genome AF: 0.00249 AC: 379AN: 152246Hom.: 1 Cov.: 32 AF XY: 0.00328 AC XY: 244AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | COL12A1: BS2 - |
COL12A1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 13, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at